申请人:Sankyo Company, Limited
公开号:US05597846A1
公开(公告)日:1997-01-28
A compound of the formula ##STR1## in which: R.sup.1 and R.sup.2 are independently selected from the group consisting of hydrogen atoms and groups of formula R.sup.3 --CO--, wherein R.sup.3 represents a group selected from the group consisting of unsubstituted alkyl groups having from 9 to 20 carbon atoms; substituted alkyl groups having from 10 to 20 carbon atoms; unsubstituted alkenyl groups having from 9 to 20 carbon atoms; substituted alkenyl group having from 10 to 20 carbon atoms; unsubstituted alkynyl groups having from 8 to 10 carbon atoms; and substituted alkynyl groups having from 8 to 10 carbon atoms wherein R.sup.1 and R.sup.2 are not both hydrogen atoms or acetyl groups. The compounds have antitumor activity.
该化合物的化学式为##STR1## 其中:R.sup.1和R.sup.2分别选自氢原子和R.sup.3 --CO--的公式组成的群,其中R.sup.3代表从未取代的烷基基团,碳原子数为9至20个;取代的烷基基团,碳原子数为10至20个;从未取代的烯基基团,碳原子数为9至20个;取代的烯基基团,碳原子数为10至20个;从未取代的炔基基团,碳原子数为8至10个;取代的炔基基团,碳原子数为8至10个,其中R.sup.1和R.sup.2不同时为氢原子或乙酰基团。该化合物具有抗肿瘤活性。